Loading…
Vapezilla LLC was cited for offering electronic nicotine delivery system (ENDS) products for sale on its website without the required premarket authorization from the FDA, violating the Federal Food, Drug, and Cosmetic Act. The company's products, which contain nicotine from any source, fall under FDA tobacco product jurisdiction and must comply with applicable regulations, including obtaining a premarket authorization order before legal marketing in the United States. The violation was identified during an FDA review of the company's website (vapezilla.com) in December 2024.